Genesis MedTech Group and the National University Health System (NUHS) have formalized a long-term strategic partnership focused on bringing AI innovation to surgery. The collaboration, an expansion of a Memorandum of Understanding signed earlier this year, was unveiled at the World Congress of Endoscopic Surgery (WCES).

At the heart of this initiative is a design-led, two-phase roadmap spanning four years. In the first phase, Genesis MedTech will work closely with NUHS surgeons to identify real-world surgical challenges  from preoperative planning to intraoperative guidance  and translate these into AI-driven device innovations. In parallel, they will establish the Genesis-NUHS AI Innovation & Surgical Training Lab, a facility that brings together engineers and clinicians to prototype, test, and validate AI tools.

NUHS clinicians will play a central role in co-innovation, ensuring that AI models and devices are aligned with clinical realities rather than theoretical use cases. The partnership underscores the importance of clinician-industry synergy Genesis MedTech brings its global R&D and product-commercialisation platform, while NUHS contributes its academic rigor, surgical expertise, and patient data.

Beyond developing new AI-assisted surgical tools, the collaboration aims to institutionalize AI adoption through training. Surgeons at NUHS will be able to refine their skills in a dedicated lab environment, leveraging real-world surgical data and simulation to work with next-gen devices. This long-term commitment reflects both organizations’ belief that safer, smarter surgery can be delivered globally  not just within Singapore.